LABCORP HOLDINGS INC. Business Exit Costs
LABCORP HOLDINGS INC. (LH) reported Business Exit Costs of $17.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:BusinessExitCosts1 · last filed 2026-02-24
- LABCORP HOLDINGS INC. business exit costs for the quarter ending 2021-12-31 was -$10.40M.
- LABCORP HOLDINGS INC. business exit costs for the quarter ending 2021-09-30 was $3.70M, a 7.50% decline year-over-year.
- LABCORP HOLDINGS INC. business exit costs for the quarter ending 2021-06-30 was $3.50M, a 16.67% decline year-over-year.
- LABCORP HOLDINGS INC. business exit costs for the quarter ending 2021-03-31 was $15.10M, a 4.43% decline year-over-year.
- LABCORP HOLDINGS INC. business exit costs for fiscal 2025 was $17.90M, a 203.39% increase from fiscal 2024.
- LABCORP HOLDINGS INC. business exit costs for fiscal 2024 was $5.90M, a 73.54% decline from fiscal 2023.
- LABCORP HOLDINGS INC. business exit costs for fiscal 2023 was $22.30M, a 28.30% decline from fiscal 2022.
- LABCORP HOLDINGS INC. business exit costs for fiscal 2022 was $31.10M, a 159.17% increase from fiscal 2021.
| Period end | Business Exit Costs 3 month | Business Exit Costs 3 month as first filed | Business Exit Costs 6 month | Business Exit Costs 9 month | Business Exit Costs 9 month as first filed | Business Exit Costs 12 month | Business Exit Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $17.90M 10-K · filed 2026-02-24 | ||||||
| 2024-12-31 | $5.90M 10-K · filed 2026-02-24 | ||||||
| 2023-12-31 | $22.30M 10-K · filed 2026-02-24 | ||||||
| 2022-12-31 | $31.10M 10-K · filed 2025-02-25 | ||||||
| 2021-12-31 | -$10.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$6.70M derived: sum of 2 quarters · filed 2024-02-26 | -$3.20M derived: sum of 3 quarters · filed 2024-02-26 | $12.00M 10-K · filed 2024-02-26 | $28.00M 10-K · filed 2023-02-28 | ||
| 2021-09-30 | $3.70M 10-Q · filed 2021-11-02 | $7.20M derived: sum of 2 quarters · filed 2021-11-02 | $22.40M 10-Q · filed 2021-11-02 | $17.20M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-06-30 | $3.50M 10-Q · filed 2021-08-05 | $18.70M 10-Q · filed 2021-08-05 | $13.50M derived: sum of 3 quarters · filed 2023-02-28 | $17.50M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2021-03-31 | $15.10M 10-Q · filed 2021-05-04 | $10.00M derived: sum of 2 quarters · filed 2023-02-28 | $14.00M derived: sum of 3 quarters · filed 2023-02-28 | $18.20M derived: sum of 4 quarters · filed 2023-02-28 | |||
| 2020-12-31 | -$5.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$1.10M derived: sum of 2 quarters · filed 2023-02-28 | $3.10M derived: sum of 3 quarters · filed 2023-02-28 | $18.90M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $4.00M 10-Q · filed 2021-11-02 | $8.20M derived: sum of 2 quarters · filed 2021-11-02 | $24.00M 10-Q · filed 2021-11-02 | $26.90M derived: sum of 4 quarters · filed 2021-11-02 | |||
| 2020-06-30 | $4.20M 10-Q · filed 2021-08-05 | $20.00M 10-Q · filed 2021-08-05 | $22.90M derived: sum of 3 quarters · filed 2021-08-05 | $31.40M derived: sum of 4 quarters · filed 2021-08-05 | |||
| 2020-03-31 | $15.80M 10-Q · filed 2020-05-08 | $18.70M derived: sum of 2 quarters · filed 2021-02-25 | $27.20M derived: sum of 3 quarters · filed 2021-02-25 | $37.40M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $11.40M derived: sum of 2 quarters · filed 2021-02-25 | $21.60M derived: sum of 3 quarters · filed 2021-02-25 | $24.90M 10-K · filed 2021-02-25 | |||
| 2019-09-30 | $8.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $18.70M derived: sum of 2 quarters · filed 2020-07-31 | $22.00M 10-Q · filed 2019-10-31 | $25.00M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | $10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | $13.50M 10-Q · filed 2020-07-31 | $16.50M derived: sum of 3 quarters · filed 2021-02-25 | $22.80M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | $3.30M 10-Q · filed 2020-05-08 | $6.30M derived: sum of 2 quarters · filed 2021-02-25 | $12.60M derived: sum of 3 quarters · filed 2021-02-25 | $13.90M derived: sum of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $9.30M derived: sum of 2 quarters · filed 2021-02-25 | $10.60M derived: sum of 3 quarters · filed 2021-02-25 | $11.80M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $6.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $7.60M derived: sum of 2 quarters · filed 2019-10-31 | $8.80M 10-Q · filed 2019-10-31 | $9.60M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-06-30 | $1.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $2.50M 10-Q · filed 2019-08-08 | $3.30M derived: sum of 3 quarters · filed 2020-02-28 | $15.40M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2018-03-31 | $1.20M 10-Q · filed 2019-05-03 | $2.00M derived: sum of 2 quarters · filed 2020-02-28 | $14.10M derived: sum of 3 quarters · filed 2020-02-28 | $18.40M derived: sum of 4 quarters · filed 2020-02-28 | |||
| 2017-12-31 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $12.90M derived: sum of 2 quarters · filed 2020-02-28 | $17.20M derived: sum of 3 quarters · filed 2020-02-28 | $18.80M 10-K · filed 2020-02-28 | |||
| 2017-09-30 | $12.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | $16.40M derived: sum of 2 quarters · filed 2018-10-30 | $18.00M 10-Q · filed 2018-10-30 | $17.90M 10-Q · filed 2017-11-02 | $21.10M derived: sum of 4 quarters · filed 2019-02-28 | ||
| 2017-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $5.90M 10-Q · filed 2018-07-27 | $9.00M derived: sum of 3 quarters · filed 2019-02-28 | $18.10M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2017-03-31 | $1.60M 10-Q · filed 2018-05-01 | $4.70M derived: sum of 2 quarters · filed 2019-02-28 | $13.80M derived: sum of 3 quarters · filed 2019-02-28 | -$4.50M derived: sum of 4 quarters · filed 2019-02-28 | |||
| 2016-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $12.20M derived: sum of 2 quarters · filed 2019-02-28 | -$6.10M derived: sum of 3 quarters · filed 2019-02-28 | $33.80M 10-K · filed 2019-02-28 | |||
| 2016-09-30 | $9.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$9.20M derived: sum of 2 quarters · filed 2017-11-02 | $30.70M 10-Q · filed 2017-11-02 | $37.40M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | -$18.30M derived: 10-Q 6 month − 10-K 3 month · filed 2017-08-02 | $21.60M 10-Q · filed 2017-08-02 | $28.30M derived: sum of 3 quarters · filed 2018-02-27 | $30.70M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | $39.90M 10-K · filed 2018-02-27 | $17.00M 10-Q · filed 2016-05-06 | $46.60M derived: sum of 2 quarters · filed 2018-02-27 | $49.00M derived: sum of 3 quarters · filed 2018-02-27 | $57.60M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $9.10M derived: sum of 2 quarters · filed 2017-02-27 | $17.70M derived: sum of 3 quarters · filed 2017-02-27 | $33.80M 10-K · filed 2017-02-27 | |||
| 2015-09-30 | $2.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $11.00M derived: sum of 2 quarters · filed 2016-10-28 | $27.10M 10-Q · filed 2016-10-28 | $76.20M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-06-30 | $8.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $24.70M 10-Q · filed 2016-07-29 | $73.80M derived: sum of 3 quarters · filed 2018-02-27 | $75.40M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-03-31 | $16.10M 10-Q · filed 2016-05-06 | $65.20M derived: sum of 2 quarters · filed 2018-02-27 | $66.80M derived: sum of 3 quarters · filed 2018-02-27 | $16.10M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2014-12-31 | $49.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $50.70M derived: sum of 2 quarters · filed 2018-02-27 | $0.00 derived: sum of 3 quarters · filed 2018-02-27 | $55.80M 10-K · filed 2018-02-27 | $8.40M 10-K · filed 2015-02-26 | ||
| 2014-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$49.10M derived: sum of 2 quarters · filed 2015-10-30 | $6.70M 10-Q · filed 2015-10-30 | $6.30M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-06-30 | -$50.70M derived: 10-Q 6 month − 10-K 3 month · filed 2015-07-30 | $5.10M 10-Q · filed 2015-07-30 | $4.70M derived: sum of 3 quarters · filed 2017-02-27 | $7.20M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-03-31 | $55.80M 10-K · filed 2017-02-27 | $4.90M 10-Q · filed 2014-04-29 | $55.40M derived: sum of 2 quarters · filed 2017-02-27 | $57.90M derived: sum of 3 quarters · filed 2017-02-27 | $62.40M derived: sum of 4 quarters · filed 2017-02-27 | ||
| 2013-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $2.10M derived: sum of 2 quarters · filed 2017-02-27 | $6.60M derived: sum of 3 quarters · filed 2017-02-27 | $8.40M 10-K · filed 2017-02-27 | $9.50M 10-K · filed 2014-02-25 | ||
| 2013-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $7.00M derived: sum of 2 quarters · filed 2014-11-10 | $8.80M 10-Q · filed 2014-11-10 | $15.80M derived: sum of 4 quarters · filed 2016-03-01 | |||
| 2013-06-30 | $4.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-29 | $6.30M 10-Q · filed 2014-07-29 | $13.30M derived: sum of 3 quarters · filed 2016-03-01 | ||||
| 2013-03-31 | $1.80M 10-Q · filed 2014-04-29 | $8.80M derived: sum of 2 quarters · filed 2016-03-01 | |||||
| 2012-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $9.50M 10-K · filed 2016-03-01 | $19.60M 10-K · filed 2014-02-25 | ||||
| 2012-09-30 | $2.50M 10-Q · filed 2013-10-28 | ||||||
| 2011-12-31 | $22.00M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |